Effective April 1, 2015, the pCODR office will be moving to 154 University Avenue, Suite 300, Toronto from its current location at 1 University Ave, Suite 300. This move is to facilitate pCODR’s transition to CADTH while maintaining its central location in downtown Toronto.
Please note the new main telephone and fax ... Read More
News & Events
25
Mar2015
25
Mar2015
PDCI is now offering a FREE TRIAL of its Canadian Drug Claims Database.
For those who are interested in the database and would like to learn more, this free trial gives registrants the opportunity to explore the database and test out its functionality at no cost!
For more information and to register, please ... Read More
12
Mar2015
Category 1 requirements for products that undergo a tailored CDR review have been revised. Submissions for new combination products (funded components) and new combination products designated by CADTH to undergo a tailored CDR review will require completion of the revised New Combination Product Submission Template. This revised template ... Read More
05
Mar2015
CADTH will be implementing an application fee for manufacturer applications filed with the pan-Canadian Oncology Drug Review (pCODR). The proposed fee will apply to all manufacturer applications with a Health Canada Notice of Compliance (NOC) or Notice of Compliance with Conditions (NOC/c) date of April 1, 2015 or later. The ... Read More
02
Mar2015
PDCI's pre-conference workshop at the upcoming Canadian Institute: Pharma Symposium Canada 2015 has been cancelled.
For those who may still be interested in the workshop, PDCI is more than happy to provide the workshop in the form of a Webinar or in-house training. Please contact Andrew Brooke for more information on ... Read More
23
Feb2015
Effective February 9, 2015 and until this process is transitioned to the pan-Canadian Pharmaceutical Alliance (pCPA) office, Saskatchewan will serve as the single point of entry for the pan-Canadian generic price tier confirmation process. The Saskatchewan Drug Plan will verify that the Tiered Pricing Framework applies to the ... Read More
04
Feb2015
Pilot Extension for Individual Patient Input to the Common Drug Review
The Common Drug Review (CDR) is extending its pilot to receive patient input submissions from individual patients and caregivers until August 3, 2015.
Pilot Extension for Patient Input for Therapeutic Reviews
CADTH implemented a pilot process for receiving patient input submissions for ... Read More
04
Feb2015
PMPRB
The PMPRB has released its January 2015 NEWSletter
Topics covered in the NEWSletter include:
Final 2014 CPI-Based Price-Adjustment Factors: The final CPI figures for 2014 are now available. Of note:
The actual CPI-based price-adjustment factor for 2 year (2012) and 3 year (2011) are lower than forecast. As a result, some manufacturers/patentees may ... Read More
14
Jan2015
QUEBEC
L’Institut national d’excellence en santé et en services sociaux (INESSS) has released the list of drug products submitted for the June 2015 “Liste des médicaments.”
Health professionals, citizens and patients and their associations and groups have until ... Read More
05
Jan2015
Common Drug Review
The Canadian Agency for Drugs and Technologies in Health posted the Canadian Drug Expert Committee (CDEC) final recommendation for its first review of a subsequent entry biologic on its website yesterday. Below is an excerpt from the CDEC Final Recommendation.
Recommendation: ... Read More